Physician profile
Ancy Mathews
NPI 1588143622
$742.33
in general payments reported to CMS, 2019-2025
8 companies · $412 in 2025
The $412 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.55 · 2022: $40.37 · 2023: $96.87 · 2024: $168 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.41 |
| Education | $194.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $238.72 | 2021-2025 | Jakafi, Niktimvo |
| Astellas Pharma US INC | $224.73 | 2025 | Xospata, Cresemba |
| Celgene Corporation | $122.96 | 2022-2023 | Reblozyl, Onureg |
| Daiichi Sankyo INC. | $56.42 | 2024 | Vanflyta |
| Janssen Biotech, INC. | $31.25 | 2025 | Darzalex, Tecvayli |
| Sanofi-Aventis U.S. LLC | $29.10 | 2024 | |
| Merck Sharp & Dohme LLC | $24.87 | 2024 | Dificid, Prevymis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ancy Mathews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.